ArticleJournal of experimental & clinical cancer research : CR2024

JAK/STAT3 represents a therapeutic target for colorectal cancer patients with stromal-rich tumors.

Kathryn A F Pennel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.